Glenmark Pharma Target

Rediff.com » News » Glenmark Pharma Target

News for Glenmark Pharma Target

Business

How Indian pharma bounced back from lockdown lows

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies — Indian drug makers have......

Markets wobble on Chinese woes, Fed hike fears

The benchmark indices slumped by around 1% in a volatile session of trade due to the negative triggers from the global front. The looming fears of a slowdown in China, Fed's signals at its latest......

Generic drug makers target US patent mart

The increasing number of patent litigations in the US against Indian pharma companies and the emergence of patent challengers such as Sun Pharma, Lupin, Orchid and Glenmark are an indication that......

Big pharmas' mega plan to beat competition in US

Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D. Indian pharma companies’ annual spending on research and......

Approval delays to hurt Indian pharma cos' US sales

Indian drugmakers expect a slowdown in new generic drug approvals by the US Food and Drug Administration (FDA) to weigh on sales in their largest market for at least two more quarters, due to an......

Glenmark Pharma Target

News for Glenmark Pharma Target

How Indian pharma bounced back from lockdown lows

Markets wobble on Chinese woes, Fed hike fears

Generic drug makers target US patent mart

Big pharmas' mega plan to beat competition in US

Approval delays to hurt Indian pharma cos' US sales

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS